Monaco Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,000
Closed -$220K 103
2024
Q4
$220K Sell
15,000
-285,000
-95% -$3.99M 0.03% 79
2024
Q3
$3.77M Sell
300,000
-36,344
-11% -$396K 0.55% 31
2024
Q2
$2.86M Buy
336,344
+43,844
+15% +$390K 0.46% 27
2024
Q1
$3.08M Sell
292,500
-57,500
-16% -$638K 0.92% 27
2023
Q4
$3.64M Sell
350,000
-66,275
-16% -$528K 1.07% 30
2023
Q3
$2.64M Buy
416,275
+6,755
+2% +$49.9K 0.78% 32
2023
Q2
$3.54M Buy
409,520
+10,420
+3% +$93.3K 0.99% 24
2023
Q1
$3.61M Sell
399,100
-100,900
-20% -$880K 1.11% 23
2022
Q4
$3.93M Buy
+500,000
New +$3.51M 1.19% 27

Other funds holding ZYME

Monaco Asset Management's ZYME Position: Q1 2025 in Review

Monaco Asset Management sold out of Zymeworks (ZYME) in Q1 2025, closing a stake of 15,000 shares — an estimated $220K sold.

Monaco Asset Management first reported a position in ZYME in Q4 2022 and held it in 9 quarters. The position peaked at $3.93M in Q4 2022. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

  • Monaco Asset Management reported no remaining Zymeworks position as of Q1 2025 after selling out during the quarter.
  • Monaco Asset Management sold 15,000 Zymeworks shares in Q1 2025, an estimated $220K.
  • Monaco Asset Management first reported a position in Zymeworks in Q4 2022 and held it in 9 quarters.
  • Monaco Asset Management's Zymeworks position peaked at $3.93M in Q4 2022.
  • 184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Monaco Asset Management's 13F filing for Q1 2025, filed 8 May 2025.